Embolotherapy Market Size, Industry Analysis Report By Product Type (Embolic Agents, Support Devices), By Disease Indication (Cancer, Peripheral Vascular Disease, Peripheral Vascular Disease, Urological & Nephrological Disorder, Gastrointestinal Disorder), By End-user (Hospitals& Clinics, Ambulatory Surgical Centre) & Region – Forecast By 2032
- PUBLISHED ON
- 1970-01-01
- NO OF PAGES
- 270
- CATEGORY
- Healthcare & Life Sciences
Embolotherapy Market is currently valued at US$ 3,545.56 Million in 2022 and is anticipated to expand at a CAGR of 8.4% to reach US$ 7,942.8 Million by 2032. Embolotherapy is a minimally invasive surgical technique used to stop and manage bleeding.
Market Growth Factors
Due to the rising incidence of cancer and the increased focus of the major players on technical breakthroughs, the market is anticipated to rise. The embolotherapy market is anticipated to increase over the course of the forecast period as a result of rising investments in the construction of healthcare infrastructure, particularly in emerging countries, and rising applications in end-use industries.
Market Trends
• Due to the rising prevalence of various types of liver cancer and the rising need for minimally invasive procedures, it is projected that the global market for embolotherapy would see increased demand.
• Additionally, it is anticipated that the market for embolotherapy would increase as a result of rising spending to upgrade healthcare infrastructure and expanding R&D for technical developments in the healthcare industry.
• The rise in patients with hepatic cell carcinoma (HCC), varicose veins, renal cell carcinoma (RCC), and aneurysms is contributing to an increase in death rates, which is fueling the expansion of the embolotherapy industry.
Segmentation
By Product Type :
o Embolic Agents
• Microspheres
• Embolic coils
• Embolic Plug Systems
• Detachable Ballons
• Liquid Embolic Agents,
• others
o Support Devices
• Microcatheters
• Guidewires
By Disease Indication :
o Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancer
o Peripheral Vascular Disease
o Peripheral Vascular Disease
o Urological & Nephrological Disorder
o Gastrointestinal Disorder
o others
By Procedure :
o Transcatheter Arterial Embolization (TAE)
o Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
o Transarterial Chemoembolization (TACE)
By End-User :
o Hospitals& Clinics
o Ambulatory Surgical Centre
o Others
Regional Analysis
With a CAGR of 8.5%, Europe is predicted to be the second-leading region for the market. Because of the rising prevalence and incidence of cancer, the accessibility of treatment, and the growing awareness of general health, the European market is expected to gradually expand.
Key Market players
The major players in the market are: Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation., Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, BTG International Limited, ABK Biomedical, Abbott, AngioDynamics, IMBIOTECHNOLOGIES LTD., Debakey Medlife Private Limited, Heraeus Holding, Guerbet, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BD among others.
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size and growth projections?
The global embolotherapy market is currently valued at US$ 3,545.56 Million in 2022 and is anticipated to expand at a CAGR of 8.4% to reach US$ 7,942.8 Million by 2032.
What are the drivers shaping various markets?
Due to the rising prevalence of various types of liver cancer and the rising need for minimally invasive procedures, it is projected that the global market for embolotherapy would see increased demand.
Who are the key competitors of market Players?
Some of the major players operating within the market are Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation., Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, BTG International Limited, ABK Biomedical, Abbott, AngioDynamics, IMBIOTECHNOLOGIES LTD., Debakey Medlife Private Limited, Heraeus Holding, Guerbet, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BD among others.
What are the top performing segments, and countries / regions of each of the markets?
The market for embolotherapy is anticipated to grow as incidences of cardiovascular illnesses rise in European nations like the U.K., Germany, and Italy.
}})
Select a license type that suits your business needs
US $4750
Only Four Thousand Seven Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5750
Only Five Thousand Seven Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $7750
Only Seven Thousand Seven Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI